Peer-reviewed research on Arbutin, summarised in plain language. Every study links to its record on PubMed so you can read it yourself.
Topical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials.
Journal of drugs in dermatology : JDD2019Systematic reviewNeutral
This large review of clinical trials mentions arbutin for melasma, but the abstract does not say how well it faded dark patches on its own.
The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split-Face, Evaluator-Blinded Randomized Pilot Study.
Journal of cosmetic dermatology2025RCT30 participants5%Mixed
In a 12-week trial of 30 people with melasma, arbutin used with kojic acid faded dark patches about as well as standard treatment, with less return after stopping.
Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study.
Journal of cosmetic science2020RCT18 participantsPositive
In a 1-month split-face trial of 18 adults with facial dark patches, a skin formula containing arbutin improved dark patches more than hydroquinone 4%.
A cream of herbal mixture to improve melasma.
Journal of cosmetic dermatology2019RCT90 participantsPositive
In a 12-week trial of 90 people with melasma, arbutin cream reduced how dark and widespread the patches were, but less than the herbal cream.
A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β-arbutin, in selected skin hyperpigmentations.
Journal of cosmetic dermatology2015RCT102 participants2.51% arbutinPositive
In an 8-week trial of 102 women with melasma or sun spots, a cream with arbutin-rich plant extract lightened dark patches more than a placebo.
Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open-label study.
The Journal of dermatology2008RCT10 participantsPositive
In a clinical trial of 10 people with melasma, arbutin put on the skin reduced how dark the patches were.
Effectiveness and Safety of Combined Use of Home-Based Radiofrequency Device and Arbutin Cream in Melasma and Facial Rejuvenation.
Journal of cosmetic dermatology2025Clinical trial38 participantsPositive
In a 38-person study, arbutin cream used with a home radiofrequency device reduced melasma over 8 weeks.
A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.
Cutis2015Clinical trial3%Positive
In people with epidermal melasma, a cream with 3% arbutin used with other ingredients reduced how dark and widespread the patches were.
Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: a prospective study.
Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology2010Clinical trial35 participants7%Positive
In a 6-month study of 35 people with melasma, a 7% arbutin solution used with laser treatment helped fade dark patches.
Aloesin inhibits hyperpigmentation induced by UV radiation.
Clinical and experimental dermatology2002Clinical trial15 participantsPositive
In a 15-day trial of 15 people, arbutin reduced UV-caused skin darkening compared with a placebo.
Research context, not treatment advice. Studies are about the ingredient, not any one product.
How we grade research for hyperpigmentationProducts we have confirmed contain Arbutin, from their ingredient lists.
We use cookies to improve your experience. Learn more